Back
ESC Premium Access

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial

Session: Drugs, devices, and multidisciplinary care in heart failure
Topic: Pharmacotherapy
Speaker: Miss N. Nouhravesh (Durham, US)
Event: ESC Congress 2024

Congress Presentation

About the speaker

Miss Nina Nouhravesh

Duke Clinical Research Institute, Durham (United States of America)
0 follower

5 more presentations in this session

Nationwide analysis of in-hospital mortality and renal infarction trends following cardiac output assist device placement from 2017 to 2020

Speaker: Doctor A. Balaji (Brooklyn, US)

Access
Abstract
Slides
Thumbnail

Beating the clock: the impact of heart failure duration on CRT efficacy

Speaker: Mr E. Grama (Barcelona, ES)

Access
Abstract
Slides
Thumbnail

Optimizing aldosterone receptor antagonist therapy by sodium zirconium cyclosilicate in heart failure - OPRA-HF trial

Speaker: Doctor C. Basic (Gothenburg, SE)

Access
Abstract
Slides
Thumbnail

Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice

Speaker: Doctor M. Wasef (Portsmouth, GB)

Access
Abstract
Slides
Video
Thumbnail

Echocardiographic evaluation of cardiac remodelling in a cohort of patients with heart failure and reduced ejection fraction treated with dapagliflozin

Speaker: Doctor J. Bonini (Ferrara, IT)

Access
Abstract
Slides
Thumbnail

Access the full session

Drugs, devices, and multidisciplinary care in heart failure

Speakers: Miss N. Nouhravesh, Doctor A. Balaji, Mr E. Grama, Doctor C. Basic, Doctor M. Wasef...
Access
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources